Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Y-4 in Healthy Subjects
NCT06935682Phase 1Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing Y-4 Tablets with Placebo (2 arms). Primary endpoints: Incidence of adverse events, Incidence of subject getting abnormal results of laboratory tests and 3 more. Started Jan 2025; status: recruiting.
02
Drugs
Y-4
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT06935682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06935682.